ABSTRACT
The purpose of this review is to discuss the rationale and indications for transvaginal ultrasound-guided biopsy. Transvaginal ultrasound-guided biopsy can be a helpful tool for diagnosis and treatment planning in the evaluation of pelvic masses, particularly when the anatomy precludes a transabdominal or posterior transgluteal percutaneous biopsy approach. A step-by-step summary of the technique with preprocedure and postprocedure considerations is included.
Subject(s)
Pelvic Neoplasms/diagnostic imaging , Ultrasonography, Interventional/methods , Female , Humans , Image-Guided Biopsy/methods , Pelvis/diagnostic imaging , Vagina/diagnostic imagingABSTRACT
A man with newly diagnosed AIDS presented with months of back pain and fever. Computed tomography (CT) results demonstrated aortitis with periaortic tissue thickening. DNA amplification of biopsy tissue revealed Bartonella quintana, and Bartonella serologies were subsequently noted to be positive. The patient improved with prolonged doxycycline and rifabutin treatment. This case illustrates how molecular techniques are increasingly important in diagnosing Bartonella infections.
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Aortitis/diagnosis , Aortitis/pathology , Bartonella quintana/isolation & purification , Trench Fever/diagnosis , Trench Fever/pathology , Anti-Bacterial Agents/therapeutic use , Antibodies, Bacterial/blood , Aortitis/drug therapy , Biopsy, Needle , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Doxycycline/therapeutic use , Genes, rRNA , Histocytochemistry , Humans , Male , Microscopy , Middle Aged , Molecular Sequence Data , Phylogeny , RNA, Ribosomal, 16S/genetics , Rifabutin/therapeutic use , Sequence Analysis, DNA , Tomography, X-Ray Computed , Treatment Outcome , Trench Fever/drug therapyABSTRACT
OBJECTIVE: To determine the characteristics of femoral condyle insufficiency fracture (FCIF) lesions and their relative associations with the risk of clinical progression. MATERIALS AND METHODS: This HIPAA-compliant retrospective study was approved by our Institutional Review Board. Seventy-three patients (age range, 19-95) were included after excluding patients with post-traumatic fractures, bone marrow infarct, osteochondritis dissecans, or underlying tumor. Two board-certified musculoskeletal radiologists classified morphologic findings including lesion diameter, associated bone marrow edema pattern, and associated cartilage/meniscus damage. Electronic medical charts were evaluated for symptoms, risk factors, and longitudinal outcomes, including total knee arthroplasty (TKA). Imaging characteristics were correlated with clinical findings, and comparison of outcome groups was performed using a regression model adjusted for age. RESULTS: The majority of patients with FCIF were women (64.4%, 47/73), on average 10 years older than men (66.28 ± 15.86 years vs. 56.54 ± 10.39 years, p = 0.005). The most common location for FCIF was the central weight-bearing surface of the medial femoral condyle; overlying full thickness cartilage loss (75.7%, 53/70) and ipsilateral meniscal injury (94.1%, 64/68) were frequently associated. Clinical outcomes were variable, with 23.9% (11/46) requiring TKA. Cartilage WORMS score, adjacent cartilage loss, and contralateral meniscal injury, in addition to decreased knee range of motion at presentation, were significantly associated with progression to TKA (p < 0.05). CONCLUSIONS: FCIF are frequently associated with overlying cartilage loss and ipsilateral meniscal injury. The extent of cartilage loss and meniscal damage, in addition to loss of knee range of motion at the time of presentation, are significantly associated with clinical progression.
Subject(s)
Cartilage Diseases/epidemiology , Femoral Fractures/epidemiology , Femoral Fractures/surgery , Fractures, Stress/epidemiology , Fractures, Stress/surgery , Osteonecrosis/epidemiology , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement, Knee/statistics & numerical data , Cartilage Diseases/pathology , Causality , Comorbidity , Female , Femoral Fractures/pathology , Fractures, Stress/pathology , Humans , Male , Middle Aged , Osteonecrosis/pathology , Prevalence , Prognosis , Retrospective Studies , Risk Assessment , San Francisco/epidemiology , Treatment Outcome , Young AdultABSTRACT
Proximal symphalangism (SYM1) is an autosomal-dominant developmental disorder of joint fusion. This disorder is best known from famous historical descriptions of two large kindred: Cushing's description in 1916 of the "straight-fingered" Brown family of Virginia and Drinkwater's description in 1917 of the British Talbot family of noble blood, descended from the English war hero John Talbot, the first Earl of Shrewsbury (1388-1453). Recent genetic studies link this phenotype to expression of abnormal genes at future joint sites: too little expression of NOG, a growth antagonist, or overexpression of GDF5, a growth agonist, results in cartilage overgrowth and bony fusion. This review unites in depth the first historical accounts of SYM1 with a clinical description and reviews the current understanding of the molecular mechanism underlying what is likely the oldest dominant trait ever studied.